Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
View ORCID ProfileWouter van Rheenen, View ORCID ProfileRick A.A. van der Spek, View ORCID ProfileMark K. Bakker, View ORCID ProfileJoke J.F.A. van Vugt, View ORCID ProfilePaul J. Hop, View ORCID ProfileRamona A.J. Zwamborn, View ORCID ProfileNiek de Klein, Harm-Jan Westra, View ORCID ProfileOlivier B. Bakker, View ORCID ProfilePatrick Deelen, View ORCID ProfileGemma Shireby, View ORCID ProfileEilis Hannon, View ORCID ProfileMatthieu Moisse, Denis Baird, View ORCID ProfileRestuadi Restuadi, View ORCID ProfileEgor Dolzhenko, Annelot M. Dekker, Klara Gawor, Henk-Jan Westeneng, Gijs H.P. Tazelaar, Kristel R. van Eijk, Maarten Kooyman, View ORCID ProfileRoss P. Byrne, Mark Doherty, View ORCID ProfileMark Heverin, View ORCID ProfileAhmad Al Khleifat, Alfredo Iacoangeli, Aleksey Shatunov, Nicola Ticozzi, Johnathan Cooper-Knock, Bradley N. Smith, View ORCID ProfileMarta Gromicho, Siddharthan Chandran, Suvankar Pal, Karen E. Morrison, Pamela J. Shaw, John Hardy, Richard W. Orrell, View ORCID ProfileMichael Sendtner, Thomas Meyer, Nazli Başak, Anneke J. van der Kooi, Antonia Ratti, View ORCID ProfileIsabella Fogh, Cinzia Gellera, Giuseppe Lauria Pinter, Stefania Corti, View ORCID ProfileCristina Cereda, Daisy Sproviero, Sandra D’Alfonso, Gianni Sorarù, Gabriele Siciliano, View ORCID ProfileMassimiliano Filosto, View ORCID ProfileAlessandro Padovani, View ORCID ProfileAdriano Chiò, Andrea Calvo, View ORCID ProfileCristina Moglia, Maura Brunetti, Antonio Canosa, Maurizio Grassano, View ORCID ProfileEttore Beghi, View ORCID ProfileElisabetta Pupillo, Giancarlo Logroscino, Beatrice Nefussy, Alma Osmanovic, View ORCID ProfileAngelica Nordin, Yossef Lerner, Michal Zabari, Marc Gotkine, Robert H. Baloh, Shaughn Bell, Patrick Vourc’h, Philippe Corcia, Philippe Couratier, View ORCID ProfileStéphanie Millecamps, Vincent Meininger, François Salachas, Jesus S. Mora Pardina, Abdelilah Assialioui, View ORCID ProfileRicardo Rojas-García, Patrick Dion, View ORCID ProfileJay P. Ross, Albert C. Ludolph, Jochen H. Weishaupt, David Brenner, Axel Freischmidt, Gilbert Bensimon, Alexis Brice, Alexandra Dürr, Christine A.M. Payan, Safa Saker-Delye, Nicholas Wood, Simon Topp, Rosa Rademakers, Lukas Tittmann, Wolfgang Lieb, Andre Franke, View ORCID ProfileStephan Ripke, View ORCID ProfileAlice Braun, View ORCID ProfileJulia Kraft, View ORCID ProfileDavid C. Whiteman, View ORCID ProfileCatherine M. Olsen, Andre G. Uitterlinden, Albert Hofman, Marcella Rietschel, Sven Cichon, Markus M. Nöthen, View ORCID ProfilePhilippe Amouyel, SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium, Bryan Traynor, Adrew B. Singleton, Miguel Mitne Neto, Ruben J. Cauchi, View ORCID ProfileRoel A. Ophoff, Martina Wiedau-Pazos, Catherine Lomen-Hoerth, Vivianna M. van Deerlin, Julian Grosskreutz, Annekathrin Rödiger, Nayana Gaur, Alexander Jörk, Tabea Barthel, Erik Theele, Benjamin Ilse, Beatrice Stubendorff, Otto W. Witte, Robert Steinbach, Christian A. Hübner, Caroline Graff, View ORCID ProfileLev Brylev, View ORCID ProfileVera Fominykh, View ORCID ProfileVera Demeshonok, View ORCID ProfileAnastasia Ataulina, View ORCID ProfileBoris Rogelj, View ORCID ProfileBlaž Koritnik, Janez Zidar, View ORCID ProfileMetka Ravnik-Glavač, View ORCID ProfileDamjan Glavač, Zorica Stević, Vivian Drory, Monica Povedano, View ORCID ProfileIan P. Blair, View ORCID ProfileMatthew C. Kiernan, View ORCID ProfileBeben Benyamin, View ORCID ProfileRobert D. Henderson, View ORCID ProfileSarah Furlong, View ORCID ProfileSusan Mathers, View ORCID ProfilePamela A. McCombe, View ORCID ProfileMerrilee Needham, View ORCID ProfileShyuan T. Ngo, View ORCID ProfileGarth A. Nicholson, View ORCID ProfileRoger Pamphlett, View ORCID ProfileDominic B. Rowe, View ORCID ProfileFrederik J. Steyn, View ORCID ProfileKelly L. Williams, View ORCID ProfileKaren Mather, View ORCID ProfilePerminder S. Sachdev, View ORCID ProfileAnjali K. Henders, View ORCID ProfileLeanne Wallace, View ORCID ProfileMamede de Carvalho, View ORCID ProfileSusana Pinto, Susanne Petri, Alma Osmanovic, View ORCID ProfileMarkus Weber, Guy A. Rouleau, View ORCID ProfileVincenzo Silani, Charles Curtis, Gerome Breen, Jonathan Glass, Robert H. Brown, John E. Landers, Christopher E. Shaw, View ORCID ProfilePeter M. Andersen, Ewout J.N. Groen, Michael A. van Es, View ORCID ProfileR. Jeroen Pasterkamp, Dongsheng Fan, View ORCID ProfileFleur C. Garton, Allan F. McRae, View ORCID ProfileGeorge Davey Smith, Tom R. Gaunt, View ORCID ProfileMichael A. Eberle, Jonathan Mill, View ORCID ProfileRussell L. McLaughlin, Orla Hardiman, Kevin P. Kenna, View ORCID ProfileNaomi R. Wray, Ellen Tsai, Heiko Runz, View ORCID ProfileLude Franke, Ammar Al-Chalabi, Philip Van Damme, View ORCID ProfileLeonard H. van den Berg, View ORCID ProfileJan H. Veldink
doi: https://doi.org/10.1101/2021.03.12.21253159
Wouter van Rheenen
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Rick A.A. van der Spek
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Mark K. Bakker
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Joke J.F.A. van Vugt
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Paul J. Hop
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Ramona A.J. Zwamborn
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Niek de Klein
2Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
Harm-Jan Westra
2Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
Olivier B. Bakker
2Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
Patrick Deelen
2Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
3Department of Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Gemma Shireby
4University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
Eilis Hannon
4University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
Matthieu Moisse
5KU Leuven – University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium
6VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium
7University Hospitals Leuven, Department of Neurology, Leuven, Belgium
Denis Baird
8Translational Biology, Biogen, Boston, Massachusetts, USA
9MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, UK
Restuadi Restuadi
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
Egor Dolzhenko
11Illumina, San Diego, California, USA
Annelot M. Dekker
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Klara Gawor
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Henk-Jan Westeneng
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Gijs H.P. Tazelaar
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Kristel R. van Eijk
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Maarten Kooyman
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Ross P. Byrne
12Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
Mark Doherty
12Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
Mark Heverin
13Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
Ahmad Al Khleifat
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Alfredo Iacoangeli
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
15Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK
16National Institute for Health Research Biomedical Research Centre and Dementia Unit, South London and Maudsley NHS Foundation Trust and King’s College London, London, UK
Aleksey Shatunov
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Nicola Ticozzi
17Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan, Italy
18Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan, Italy
Johnathan Cooper-Knock
19Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
Bradley N. Smith
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Marta Gromicho
20Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Siddharthan Chandran
21Euan MacDonald Centre for Motor Neurone Disease Research, Edinburgh, UK
22Centre for Neuroregeneration and Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
Suvankar Pal
21Euan MacDonald Centre for Motor Neurone Disease Research, Edinburgh, UK
22Centre for Neuroregeneration and Medical Research Council Centre for Regenerative Medicine, University of Edinburgh, Edinburgh, UK
Karen E. Morrison
23School of Medicine, Dentistry, and Biomedical Sciences, Queen’s University Belfast, Belfast, UK
Pamela J. Shaw
19Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK
John Hardy
24Department of Molecular Neuroscience, Institute of Neurology, University College London, London, UK
Richard W. Orrell
25Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, UK
Michael Sendtner
26Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany
Thomas Meyer
27Charité University Hospital, Humboldt-University, Berlin, Germany
Nazli Başak
28Neurodegeneration Research Laboratory, Bogazici University, Istanbul, Turkey
Anneke J. van der Kooi
29Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
Antonia Ratti
17Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan, Italy
30Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milan, Italy
Isabella Fogh
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Cinzia Gellera
31Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, Milan, Italy
Giuseppe Lauria Pinter
323rd Neurology Unit, Motor Neuron Diseases Center, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, MIlan, Italy
33‘L. Sacco’ Department of Biomedical and Clinical Sciences, Università degli Studi di Milano, Milan, Italy
Stefania Corti
34Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
18Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan, Italy
Cristina Cereda
35Genomic and Post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy
Daisy Sproviero
35Genomic and Post-Genomic Center, IRCCS Mondino Foundation, Pavia, Italy
Sandra D’Alfonso
36Department of Health Sciences, University of Eastern Piedmont, Novara, Italy
Gianni Sorarù
37Department of Neurosciences, University of Padova, Padova, Italy
Gabriele Siciliano
38Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Massimiliano Filosto
39Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
Alessandro Padovani
39Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
Adriano Chiò
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
41Neurologia 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
Andrea Calvo
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
41Neurologia 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
Cristina Moglia
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
41Neurologia 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
Maura Brunetti
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
Antonio Canosa
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
41Neurologia 1, Azienda Ospedaliero Universitaria Città della Salute e della Scienza, Turin, Italy
Maurizio Grassano
40“Rita Levi Montalcini” Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy
Ettore Beghi
42Laboratory of Neurological Diseases, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Elisabetta Pupillo
42Laboratory of Neurological Diseases, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy
Giancarlo Logroscino
43Department of Clinical Research in Neurology, University of Bari at “Pia Fondazione Card G. Panico” Hospital, Bari, Italy
Beatrice Nefussy
44Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel
Alma Osmanovic
45Department of Neurology, Hannover Medical School, Hannover, Germany
Angelica Nordin
46Department of Clinical Sciences, Neurosciences, Umeå University, SE-901 85 Umeå, Sweden
Yossef Lerner
47Faculty of Medicine, Hebrew University of Jerusalem, Israel
48The Agnes Ginges Center for Human Neurogenetics, Dept. of Neurology, Hadassah Medical Center, Jerusalem, Israel
Michal Zabari
47Faculty of Medicine, Hebrew University of Jerusalem, Israel
48The Agnes Ginges Center for Human Neurogenetics, Dept. of Neurology, Hadassah Medical Center, Jerusalem, Israel
Marc Gotkine
47Faculty of Medicine, Hebrew University of Jerusalem, Israel
48The Agnes Ginges Center for Human Neurogenetics, Dept. of Neurology, Hadassah Medical Center, Jerusalem, Israel
Robert H. Baloh
49Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA
50Department of Neurology, Neuromuscular Division, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA
Shaughn Bell
49Center for Neural Science and Medicine, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA
50Department of Neurology, Neuromuscular Division, Cedars-Sinai Medical Center, Los Angeles, California, 90048, USA
Patrick Vourc’h
51Service de Biochimie et Biologie moléculaire, CHU de Tours, Tours, France
52UMR 1253, Université de Tours, Inserm, 37044 Tours, France
Philippe Corcia
53Centre de référence sur la SLA, CHU de Tours, Tours, France
52UMR 1253, Université de Tours, Inserm, 37044 Tours, France
Philippe Couratier
54Centre de référence sur la SLA, CHRU de Limoges, Limoges, France
55UMR 1094, Université de Limoges, Inserm, 87025 Limoges, France
Stéphanie Millecamps
56ICM, Institut du Cerveau, Inserm, CNRS, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France
Vincent Meininger
57Hôpital des Peupliers, Ramsay Générale de Santé, 75013 Paris, France
François Salachas
58Département de Neurologie, Centre de référence SLA Ile de France, Hôpital de la Pitié Salpêtrière, AP-HP, Paris, France
56ICM, Institut du Cerveau, Inserm, CNRS, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France
Jesus S. Mora Pardina
59ALS Unit, Hospital San Rafael, Madrid, Spain
Abdelilah Assialioui
60Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
Ricardo Rojas-García
61MND Clinic, Neurology Department, Hospital de la Santa Creu i Sant Pau de Barcelona, Universitat Autonoma de Barcelona, Barcelona, Spain
Patrick Dion
62Montreal Neurological Institute and Hospital, McGill University, Montréal H3A 2B4, Canada
Jay P. Ross
62Montreal Neurological Institute and Hospital, McGill University, Montréal H3A 2B4, Canada
63Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada
Albert C. Ludolph
64Department of Neurology, Ulm University, Ulm, Germany
Jochen H. Weishaupt
65Division of Neurodegeneration, Department of Neurology, University Medicine Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
David Brenner
65Division of Neurodegeneration, Department of Neurology, University Medicine Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany
Axel Freischmidt
64Department of Neurology, Ulm University, Ulm, Germany
66German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany
Gilbert Bensimon
67Département de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière, UPMC Pharmacologie, AP-HP, Paris, France
Alexis Brice
68INSERM U289, Hôpital Salpêtrière, AP-HP, Paris, France
69Département de Génétique, Cytogénétique et Embryologie, Hôpital Salpêtrière, AP-HP, Paris, France
70Fédération de Neurologie, Hôpital Salpêtrière, AP-HP, Paris, France
Alexandra Dürr
71Department of Medical Genetics, L’Institut du Cerveau et de la Moelle Épinière, Hôpital Salpêtrière, Paris, France
Christine A.M. Payan
67Département de Pharmacologie Clinique, Hôpital de la Pitié-Salpêtrière, UPMC Pharmacologie, AP-HP, Paris, France
Safa Saker-Delye
72Genethon, CNRS UMR, 8587 Evry, France
Nicholas Wood
73Department of Neurogenetics, UCL Institute of Neurology, Queen Square, London, UK
Simon Topp
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Rosa Rademakers
74Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, Florida, USA
Lukas Tittmann
75Popgen Biobank and Institute of Epidemiology, Christian Albrechts-University Kiel, Kiel, Germany
Wolfgang Lieb
75Popgen Biobank and Institute of Epidemiology, Christian Albrechts-University Kiel, Kiel, Germany
Andre Franke
76Institute of Clinical Molecular Biology, Kiel University, Kiel, Germany
Stephan Ripke
77Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts, USA
78Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
79Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin 10117, Germany
Alice Braun
79Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin 10117, Germany
Julia Kraft
79Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin, Berlin 10117, Germany
David C. Whiteman
80Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia
Catherine M. Olsen
80Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia
Andre G. Uitterlinden
81Department of Internal Medicine, Genetics Laboratory, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
82Department of Epidemiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Albert Hofman
82Department of Epidemiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Marcella Rietschel
83Central Institute of Mental Health, Mannheim, Germany; Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
Sven Cichon
84Institute of Human Genetics, University of Bonn, Bonn, Germany
85Department of Genomics, Life and Brain Center, Bonn, Germany
86Division of Medical Genetics, University Hospital Basel and Department of Biomedicine, University of Basel, Basel, Switzerland
87Institute of Neuroscience and Medicine INM-1, Research Center Juelich, Juelich, Germany
Markus M. Nöthen
84Institute of Human Genetics, University of Bonn, Bonn, Germany
85Department of Genomics, Life and Brain Center, Bonn, Germany
Philippe Amouyel
88Univ. Lille, Inserm, Centre Hosp. Univ. Lille, Institut Pasteur de Lille, UMR1167 - RID-AGE LabEx DISTALZ - Risk factors and molecular determinants of aging-related diseases, F-59000 Lille, France
Bryan Traynor
89Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Porter Neuroscience Research Center, Bethesda, Maryland, USA
90Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA
Adrew B. Singleton
91Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, NIH, Porter Neuroscience Research Center, Bethesda, Maryland, USA
Miguel Mitne Neto
92Universidade de São Paulo, São Paulo, Brazil
Ruben J. Cauchi
93Centre for Molecular Medicine and Biobanking & Department of Physiology and Biochemistry, Faculty of Medicine and Surgery, University of Malta, Malta
Roel A. Ophoff
94University Medical Center Utrecht, Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, The Netherlands
95Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, USA
96Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA
Martina Wiedau-Pazos
97Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
Catherine Lomen-Hoerth
98Department of Neurology, University of California, San Francisco, California, USA
Vivianna M. van Deerlin
99Center for Neurodegenerative Disease Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
Julian Grosskreutz
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Annekathrin Rödiger
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Nayana Gaur
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Alexander Jörk
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Tabea Barthel
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Erik Theele
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Benjamin Ilse
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Beatrice Stubendorff
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Otto W. Witte
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Robert Steinbach
100Hans-Berger-Department of Neurology, Jena University Hospital, Jena, Germany
Christian A. Hübner
101Institute of Human Genetics, Jena University Hospital, Jena, Germany
Caroline Graff
102Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden
Lev Brylev
103Department of Neurology, Bujanov Moscow Clinical Hospital, Moscow, Russia
104Moscow Research and Clinical Center for Neuropsychiatry of the Healthcare Department, Moscow, Russia
105Department of Functional Biochemistry of the Nervous System, Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia
Vera Fominykh
103Department of Neurology, Bujanov Moscow Clinical Hospital, Moscow, Russia
105Department of Functional Biochemistry of the Nervous System, Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Sciences, Moscow, Russia
Vera Demeshonok
106ALS-care center, “GAOORDI”, Medical Clinic of the St. Petersburg, St. Petersburg, Russia
Anastasia Ataulina
103Department of Neurology, Bujanov Moscow Clinical Hospital, Moscow, Russia
Boris Rogelj
107Department of Biotechnology, Jožef Stefan Institute, Ljubljana, Slovenia
108Biomedical Research Institute BRIS, Ljubljana, Slovenia
109Faculty of Chemistry and Chemical Technology, Universtiy of Ljubljana, Ljubljana, Slovenia
Blaž Koritnik
110Ljubljana ALS Centre, Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Janez Zidar
110Ljubljana ALS Centre, Institute of Clinical Neurophysiology, University Medical Centre Ljubljana, Ljubljana, Slovenia
Metka Ravnik-Glavač
111Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Damjan Glavač
112Department of Molecular Genetics, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Zorica Stević
113Clinic of Neurology, Clinical Center of Serbia, School of Medicine, University of Belgrade, Belgrade, Serbia
Vivian Drory
44Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel
Monica Povedano
60Functional Unit of Amyotrophic Lateral Sclerosis (UFELA), Service of Neurology, Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona, Spain
Ian P. Blair
114Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia
Matthew C. Kiernan
115Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia
Beben Benyamin
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
116Australian Centre for Precision Health & Allied Health and Human Performance, University of South Australia, Adelaide, SA 5001 Australia
Robert D. Henderson
117Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
118Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia
119Fiona Stanley Hospital, Perth, WA 6150, Australia
Sarah Furlong
114Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia
Susan Mathers
120Calvary Health Care Bethlehem, Parkdale, VIC 3195, Australia
Pamela A. McCombe
117Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
121Department of Neurology, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Merrilee Needham
119Fiona Stanley Hospital, Perth, WA 6150, Australia
122Notre Dame University, Fremantle, WA 6160, Australia
123Institute for Immunology and Infectious Diseases, Murdoch University, Perth, WA 6150, Australia
Shyuan T. Ngo
117Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
124The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland, Australia
118Centre for Clinical Research, The University of Queensland, Brisbane, Queensland, Australia
Garth A. Nicholson
114Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia
Roger Pamphlett
125Discipline of Pathology and Department of Neuropathology, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia
Dominic B. Rowe
114Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia
Frederik J. Steyn
126The School of Biomedical Sciences, Faculty of Medicine, The University of Queensland, Brisbane, QLD 4074, Australia
121Department of Neurology, Royal Brisbane and Women’s Hospital, Brisbane, QLD 4029, Australia
Kelly L. Williams
114Centre for Motor Neuron Disease Research, Faculty of Medicine, Health and Human Sciences, Macquarie University, NSW 2109, Australia
Karen Mather
127Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW 2031, Australia
128Neuroscience Research Australia Institute, Randwick, NSW 2031, Australia
Perminder S. Sachdev
127Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, NSW 2031, Australia
129Neuropsychiatric Institute, The Prince of Wales Hospital, UNSW, Randwick, NSW 2031, Australia
Anjali K. Henders
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
Leanne Wallace
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
Mamede de Carvalho
20Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Susana Pinto
20Instituto de Fisiologia, Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Susanne Petri
45Department of Neurology, Hannover Medical School, Hannover, Germany
Alma Osmanovic
45Department of Neurology, Hannover Medical School, Hannover, Germany
Markus Weber
130Neuromuscular Diseases Unit/ALS Clinic, Kantonsspital St. Gallen, 9007, St. Gallen, Switzerland
Guy A. Rouleau
62Montreal Neurological Institute and Hospital, McGill University, Montréal H3A 2B4, Canada
Vincenzo Silani
17Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, Milan, Italy
18Department of Pathophysiology and Transplantation, “Dino Ferrari” Center, Università degli Studi di Milano, Milan, Italy
Charles Curtis
131MRC Social, Genetic and Developmental Psychiatry Centre, King’s College London, London, UK
Gerome Breen
132IoPPN Genomics & Biomarker Core, Translational Genetics Group, MRC Social, Genetic and Developmental Psychiatry Centre, King’s College London, London, UK
133NIHR Biomedical Research Centre for Mental Health, Maudsley Hospital and Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Jonathan Glass
134Department Neurology, Emory University School of Medicine, Atlanta, Georgia, USA
Robert H. Brown
135Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
John E. Landers
135Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts, USA
Christopher E. Shaw
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Peter M. Andersen
46Department of Clinical Sciences, Neurosciences, Umeå University, SE-901 85 Umeå, Sweden
Ewout J.N. Groen
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Michael A. van Es
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
R. Jeroen Pasterkamp
136Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Dongsheng Fan
137Department of Neurology, Peking University, Third Hospital, No. 49, North Garden Road, Haidian District, Beijing, 100191, China
Fleur C. Garton
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
Allan F. McRae
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
George Davey Smith
9MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, UK
138Population Health Science, Bristol Medical School, Bristol, Bristol BS8 1TH, UK
Tom R. Gaunt
9MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, UK
138Population Health Science, Bristol Medical School, Bristol, Bristol BS8 1TH, UK
Michael A. Eberle
11Illumina, San Diego, California, USA
Jonathan Mill
4University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
Russell L. McLaughlin
12Complex Trait Genomics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin D02 PN40, Ireland
Orla Hardiman
13Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin D02 PN40, Ireland
Kevin P. Kenna
136Department of Translational Neuroscience, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Naomi R. Wray
10Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
117Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia
Ellen Tsai
8Translational Biology, Biogen, Boston, Massachusetts, USA
Heiko Runz
8Translational Biology, Biogen, Boston, Massachusetts, USA
Lude Franke
2Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands
Ammar Al-Chalabi
14Maurice Wohl Clinical Neuroscience Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
139King’s College Hospital, Denmark Hill, SE5 9RS London, UK
Philip Van Damme
5KU Leuven – University of Leuven, Department of Neurosciences, Experimental Neurology, and Leuven Brain Institute (LBI), Leuven, Belgium
6VIB, Center for Brain & Disease Research, Laboratory of Neurobiology, Leuven, Belgium
7University Hospitals Leuven, Department of Neurology, Leuven, Belgium
Leonard H. van den Berg
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Jan H. Veldink
1Department of Neurology, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a life-time risk of 1 in 350 people and an unmet need for disease-modifying therapies. We conducted a cross-ancestry GWAS in ALS including 29,612 ALS patients and 122,656 controls which identified 15 risk loci in ALS. When combined with 8,953 whole-genome sequenced individuals (6,538 ALS patients, 2,415 controls) and the largest cortex-derived eQTL dataset (MetaBrain), analyses revealed locus-specific genetic architectures in which we prioritized genes either through rare variants, repeat expansions or regulatory effects. ALS associated risk loci were shared with multiple traits within the neurodegenerative spectrum, but with distinct enrichment patterns across brain regions and cell-types. Across environmental and life-style risk factors obtained from literature, Mendelian randomization analyses indicated a causal role for high cholesterol levels. All ALS associated signals combined reveal a role for perturbations in vesicle mediated transport and autophagy, and provide evidence for cell-autonomous disease initiation in glutamatergic neurons.
Competing Interest Statement
Jan Veldink has sponsored research agreements with Biogen Idec. Leonard van den Berg receives personal fees from Cytokinetics, outside the submitted work. Ammar Al-Chalabi has served on scientific advisory boards for Mitsubishi Tanabe Pharma, OrionPharma, Biogen Idec, Lilly, GSK, Apellis, Amylyx, and Wave Therapeutics. Adriano Chio serves on scientific advisory boards for Mitsubishi Tanabe, Roche, Biogen, Denali, and Cytokinetics.
Funding Statement
W.v.R. is supported by funding provided by the Dutch Research Council (NWO) [VENI scheme grant 09150161810018] and Prinses Beatrix Spierfond (neuromuscular fellowship grant W.F19-03). J.J.F.A.v.V. is funded by Projectnumber W.OR20-08 (The Repeatome as a basis for new treatments of ALS) of the Prinses Beatrix Spierfonds. K.P.K. is supported by funding provided by the Dutch Research Council (NWO) [VIDI grant 91719350]. G.S. was supported by a PhD studentship from the Alzheimers Society. E.H. and J.M. were supported by Medical Research Council (MRC) grant K013807 (awarded to J.M). mQTL SMR data analysis was undertaken using high-performance computing supported by a Medical Research Council (MRC) Clinical Infrastructure award M008924 (awarded to J.M.). French ALS patients of the Pitie-Salpetriere hospital (Paris) have been collected with ARSla funding support. D.B. and T.R.G. received funding from Biogen and UK Medical Research Council (MRC Epidemiology Unit, MC_UU_00011/1 and MC_UU_00011/4) for this project. G.D.S. works in the Medical Research Council Integrative Epidemiology Unit at the University of Bristol MC_UU_00011/1. D.B., E. Tsai and H.R. are employees of Biogen. J.P.R. is funded by the Canadian Institutes of Health Research (FRN 159279). A.A.K is supported by The Motor Neurone Disease Association (MNDA) and NIHR Maudsley Biomedical Research Centre. R.J.P. is supported by the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO; BRAINSCAPES). Project MinE Belgium was supported by a grant from IWT (# 140935), the ALS Liga Belgium, the National Lottery of Belgium and the KU Leuven Opening the Future Fund (awarded to P.V.D.). P.V.D holds a senior clinical investigatorship of FWO-Vlaanderen and is supported by the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders, the ALS Liga Belgium and the KU Leuven funds ‘Een Hart voor ALS’, ‘Laeversfonds voor ALS Onderzoek’ and the ‘Valery Perrier Race against ALS Fund’. Several authors of this publication are members of the European Reference Network for Rare Neuromuscular Diseases (ERN-NMD). The authors are pleased to acknowledge the contribution of `Live now` Charity Foundation and Moscow ALS palliative care service for supporting patients with ALS and their families. G.A.R is supported by the Canadian Institutes of Health. Research Australia including its Ice Bucket Challenge Grant. We acknowledge funding from the National Health and Medical Research Council (NHMRC) (1078901, 1083187, 1113400, 1095215, 1121962, 1173790, Enabling Grant #402703). The Older Australian Twins Study (OATS, used for controls) acknowledges funding from the NHMRC/Australian Research Council Strategic Award (401162) and NHMRC (1405325, 1024224, 1025243, 1045325, 1085606, 568969, 1093083). OATS was facilitated through access to Twins Research Australia, a national resource supported by a NHMRC Centre of Research Excellence Grant (1079102). The Sydney Memory and Ageing Study (Sydney MAS, used for controls) has been funded by three NHMRC Program Grants (350833, 568969, and 1093083). We also acknowledge the OATS and Sydney MAS research teams: https://cheba.unsw.edu.au/research-projects/sydney-memory-and-ageing-study; https://cheba.unsw.edu.au/project/older-australian-twins-study. D.C.W. is supported by a Research Fellowship [APP1155413] from the National Health and Medical Research Council of Australia (NHMRC). The QSkin Study is supported by Grants [APP1185416, APP1073898, APP1063061] from the National Health and Medical Research Council of Australia (NHMRC). Several authors of this publication are members of the Netherlands Neuromuscular Center (NL-NMD) and the European Reference Network for rare neuromuscular diseases EURO-NMD. PJS is supported as an 43 NIHR Senior Investigator and by the Sheffield NIHR Biomedical Research Centre. This is in part an EU Joint Programme - Neurodegenerative Disease Research (JPND) project. The project is supported through the following funding organisations under the aegis of JPND - www.jpnd.eu (United Kingdom, Medical Research Council (MR/L501529/1; MR/R024804/1) and Economic and Social Research Council (ES/L008238/1)) and through the Motor Neurone Disease Association. This study represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London. A.A-C is supported by an NIHR Senior Investigator Award. Samples used in this research were in part obtained from the UK National DNA Bank for MND Research, funded by the MND Association and the Wellcome Trust. We would like to thank people with MND and their families for their participation in this project. We acknowledge sample management undertaken by Biobanking Solutions funded by the Medical Research Council at the Centre for Integrated Genomic Medical Research, University of Manchester. L.H.v.d.B. reports grants from The Netherlands Organization for Health Research and Development (Vici scheme), grants from The European Community's Health Seventh Framework Programme (grant agreement # 259867 (EuroMOTOR)), grants from The Netherlands Organization for Health Research and Development) the STRENGTH project, funded through the EU Joint Programme - Neurodegenerative Disease Research, JPND). This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement # 772376 - EScORIAL). The collaboration project is co-funded by the PPP Allowance made available by Health∼Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships. This study was supported by the ALS Foundation Netherlands.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Please see attached .tsv file as requested
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All summary statistics will be made publicly available in centralized repositories upon publication after peer review.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Posted March 15, 2021.
Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A.A. van der Spek, Mark K. Bakker, Joke J.F.A. van Vugt, Paul J. Hop, Ramona A.J. Zwamborn, Niek de Klein, Harm-Jan Westra, Olivier B. Bakker, Patrick Deelen, Gemma Shireby, Eilis Hannon, Matthieu Moisse, Denis Baird, Restuadi Restuadi, Egor Dolzhenko, Annelot M. Dekker, Klara Gawor, Henk-Jan Westeneng, Gijs H.P. Tazelaar, Kristel R. van Eijk, Maarten Kooyman, Ross P. Byrne, Mark Doherty, Mark Heverin, Ahmad Al Khleifat, Alfredo Iacoangeli, Aleksey Shatunov, Nicola Ticozzi, Johnathan Cooper-Knock, Bradley N. Smith, Marta Gromicho, Siddharthan Chandran, Suvankar Pal, Karen E. Morrison, Pamela J. Shaw, John Hardy, Richard W. Orrell, Michael Sendtner, Thomas Meyer, Nazli Başak, Anneke J. van der Kooi, Antonia Ratti, Isabella Fogh, Cinzia Gellera, Giuseppe Lauria Pinter, Stefania Corti, Cristina Cereda, Daisy Sproviero, Sandra D’Alfonso, Gianni Sorarù, Gabriele Siciliano, Massimiliano Filosto, Alessandro Padovani, Adriano Chiò, Andrea Calvo, Cristina Moglia, Maura Brunetti, Antonio Canosa, Maurizio Grassano, Ettore Beghi, Elisabetta Pupillo, Giancarlo Logroscino, Beatrice Nefussy, Alma Osmanovic, Angelica Nordin, Yossef Lerner, Michal Zabari, Marc Gotkine, Robert H. Baloh, Shaughn Bell, Patrick Vourc’h, Philippe Corcia, Philippe Couratier, Stéphanie Millecamps, Vincent Meininger, François Salachas, Jesus S. Mora Pardina, Abdelilah Assialioui, Ricardo Rojas-García, Patrick Dion, Jay P. Ross, Albert C. Ludolph, Jochen H. Weishaupt, David Brenner, Axel Freischmidt, Gilbert Bensimon, Alexis Brice, Alexandra Dürr, Christine A.M. Payan, Safa Saker-Delye, Nicholas Wood, Simon Topp, Rosa Rademakers, Lukas Tittmann, Wolfgang Lieb, Andre Franke, Stephan Ripke, Alice Braun, Julia Kraft, David C. Whiteman, Catherine M. Olsen, Andre G. Uitterlinden, Albert Hofman, Marcella Rietschel, Sven Cichon, Markus M. Nöthen, Philippe Amouyel, SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium, Bryan Traynor, Adrew B. Singleton, Miguel Mitne Neto, Ruben J. Cauchi, Roel A. Ophoff, Martina Wiedau-Pazos, Catherine Lomen-Hoerth, Vivianna M. van Deerlin, Julian Grosskreutz, Annekathrin Rödiger, Nayana Gaur, Alexander Jörk, Tabea Barthel, Erik Theele, Benjamin Ilse, Beatrice Stubendorff, Otto W. Witte, Robert Steinbach, Christian A. Hübner, Caroline Graff, Lev Brylev, Vera Fominykh, Vera Demeshonok, Anastasia Ataulina, Boris Rogelj, Blaž Koritnik, Janez Zidar, Metka Ravnik-Glavač, Damjan Glavač, Zorica Stević, Vivian Drory, Monica Povedano, Ian P. Blair, Matthew C. Kiernan, Beben Benyamin, Robert D. Henderson, Sarah Furlong, Susan Mathers, Pamela A. McCombe, Merrilee Needham, Shyuan T. Ngo, Garth A. Nicholson, Roger Pamphlett, Dominic B. Rowe, Frederik J. Steyn, Kelly L. Williams, Karen Mather, Perminder S. Sachdev, Anjali K. Henders, Leanne Wallace, Mamede de Carvalho, Susana Pinto, Susanne Petri, Alma Osmanovic, Markus Weber, Guy A. Rouleau, Vincenzo Silani, Charles Curtis, Gerome Breen, Jonathan Glass, Robert H. Brown, John E. Landers, Christopher E. Shaw, Peter M. Andersen, Ewout J.N. Groen, Michael A. van Es, R. Jeroen Pasterkamp, Dongsheng Fan, Fleur C. Garton, Allan F. McRae, George Davey Smith, Tom R. Gaunt, Michael A. Eberle, Jonathan Mill, Russell L. McLaughlin, Orla Hardiman, Kevin P. Kenna, Naomi R. Wray, Ellen Tsai, Heiko Runz, Lude Franke, Ammar Al-Chalabi, Philip Van Damme, Leonard H. van den Berg, Jan H. Veldink
medRxiv 2021.03.12.21253159; doi: https://doi.org/10.1101/2021.03.12.21253159
Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
Wouter van Rheenen, Rick A.A. van der Spek, Mark K. Bakker, Joke J.F.A. van Vugt, Paul J. Hop, Ramona A.J. Zwamborn, Niek de Klein, Harm-Jan Westra, Olivier B. Bakker, Patrick Deelen, Gemma Shireby, Eilis Hannon, Matthieu Moisse, Denis Baird, Restuadi Restuadi, Egor Dolzhenko, Annelot M. Dekker, Klara Gawor, Henk-Jan Westeneng, Gijs H.P. Tazelaar, Kristel R. van Eijk, Maarten Kooyman, Ross P. Byrne, Mark Doherty, Mark Heverin, Ahmad Al Khleifat, Alfredo Iacoangeli, Aleksey Shatunov, Nicola Ticozzi, Johnathan Cooper-Knock, Bradley N. Smith, Marta Gromicho, Siddharthan Chandran, Suvankar Pal, Karen E. Morrison, Pamela J. Shaw, John Hardy, Richard W. Orrell, Michael Sendtner, Thomas Meyer, Nazli Başak, Anneke J. van der Kooi, Antonia Ratti, Isabella Fogh, Cinzia Gellera, Giuseppe Lauria Pinter, Stefania Corti, Cristina Cereda, Daisy Sproviero, Sandra D’Alfonso, Gianni Sorarù, Gabriele Siciliano, Massimiliano Filosto, Alessandro Padovani, Adriano Chiò, Andrea Calvo, Cristina Moglia, Maura Brunetti, Antonio Canosa, Maurizio Grassano, Ettore Beghi, Elisabetta Pupillo, Giancarlo Logroscino, Beatrice Nefussy, Alma Osmanovic, Angelica Nordin, Yossef Lerner, Michal Zabari, Marc Gotkine, Robert H. Baloh, Shaughn Bell, Patrick Vourc’h, Philippe Corcia, Philippe Couratier, Stéphanie Millecamps, Vincent Meininger, François Salachas, Jesus S. Mora Pardina, Abdelilah Assialioui, Ricardo Rojas-García, Patrick Dion, Jay P. Ross, Albert C. Ludolph, Jochen H. Weishaupt, David Brenner, Axel Freischmidt, Gilbert Bensimon, Alexis Brice, Alexandra Dürr, Christine A.M. Payan, Safa Saker-Delye, Nicholas Wood, Simon Topp, Rosa Rademakers, Lukas Tittmann, Wolfgang Lieb, Andre Franke, Stephan Ripke, Alice Braun, Julia Kraft, David C. Whiteman, Catherine M. Olsen, Andre G. Uitterlinden, Albert Hofman, Marcella Rietschel, Sven Cichon, Markus M. Nöthen, Philippe Amouyel, SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium, Bryan Traynor, Adrew B. Singleton, Miguel Mitne Neto, Ruben J. Cauchi, Roel A. Ophoff, Martina Wiedau-Pazos, Catherine Lomen-Hoerth, Vivianna M. van Deerlin, Julian Grosskreutz, Annekathrin Rödiger, Nayana Gaur, Alexander Jörk, Tabea Barthel, Erik Theele, Benjamin Ilse, Beatrice Stubendorff, Otto W. Witte, Robert Steinbach, Christian A. Hübner, Caroline Graff, Lev Brylev, Vera Fominykh, Vera Demeshonok, Anastasia Ataulina, Boris Rogelj, Blaž Koritnik, Janez Zidar, Metka Ravnik-Glavač, Damjan Glavač, Zorica Stević, Vivian Drory, Monica Povedano, Ian P. Blair, Matthew C. Kiernan, Beben Benyamin, Robert D. Henderson, Sarah Furlong, Susan Mathers, Pamela A. McCombe, Merrilee Needham, Shyuan T. Ngo, Garth A. Nicholson, Roger Pamphlett, Dominic B. Rowe, Frederik J. Steyn, Kelly L. Williams, Karen Mather, Perminder S. Sachdev, Anjali K. Henders, Leanne Wallace, Mamede de Carvalho, Susana Pinto, Susanne Petri, Alma Osmanovic, Markus Weber, Guy A. Rouleau, Vincenzo Silani, Charles Curtis, Gerome Breen, Jonathan Glass, Robert H. Brown, John E. Landers, Christopher E. Shaw, Peter M. Andersen, Ewout J.N. Groen, Michael A. van Es, R. Jeroen Pasterkamp, Dongsheng Fan, Fleur C. Garton, Allan F. McRae, George Davey Smith, Tom R. Gaunt, Michael A. Eberle, Jonathan Mill, Russell L. McLaughlin, Orla Hardiman, Kevin P. Kenna, Naomi R. Wray, Ellen Tsai, Heiko Runz, Lude Franke, Ammar Al-Chalabi, Philip Van Damme, Leonard H. van den Berg, Jan H. Veldink
medRxiv 2021.03.12.21253159; doi: https://doi.org/10.1101/2021.03.12.21253159
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)